Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


acgp加速器跑路了-outline

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

acgp加速器跑路了-outline

acgp加速器跑路了-outline

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

acgp加速器跑路了-outline

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
跳墙vpn  (永久免费)加速器下载官网  神灯 vp 加速  letsvpn app下载  快连 电脑  快连vpn永远都能连得上VPN官方  熊猫加速器下载链接  极光vp n官网aurora安卓